NERV - Minerva Neurosciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5264.59M
Enterprise Value 3209.71M
Trailing P/E N/A
Forward P/E 1-3.46
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.93
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-3.80

Trading Information

Stock Price History

Beta (3Y Monthly) 1.50
52-Week Change 3-25.24%
S&P500 52-Week Change 32.31%
52 Week High 312.95
52 Week Low 34.07
50-Day Moving Average 36.68
200-Day Moving Average 36.79

Share Statistics

Avg Vol (3 month) 3774.03k
Avg Vol (10 day) 3247.22k
Shares Outstanding 539.03M
Float 33.54M
% Held by Insiders 13.79%
% Held by Institutions 181.12%
Shares Short (Jul 31, 2019) 41.83M
Short Ratio (Jul 31, 2019) 44.67
Short % of Float (Jul 31, 2019) 47.44%
Short % of Shares Outstanding (Jul 31, 2019) 44.69%
Shares Short (prior month Jun 28, 2019) 41.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.57%
Return on Equity (ttm)-60.17%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -55.25M
Net Income Avi to Common (ttm)-53.53M
Diluted EPS (ttm)-1.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)69.29M
Total Cash Per Share (mrq)1.78
Total Debt (mrq)362.67k
Total Debt/Equity (mrq)0.54
Current Ratio (mrq)9.34
Book Value Per Share (mrq)1.72

Cash Flow Statement

Operating Cash Flow (ttm)-39.51M
Levered Free Cash Flow (ttm)-19.92M